Sign in
4

Changes in Ownership

AN2 Therapeutics, Inc. Filed Acc 0000899243-22-034294

Chief Executive Officer sold 9,350 shares at an average $15.76 ($147,358)

From the SEC's structured data for this filing

Trades in this filing

Easom Eric · Chief Executive Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2022-10-24 Sale : show line 1 in the form −2,866 $16.17 $46,344 11,391 D
2022-10-25 Sale : show line 2 in the form −4,272 $15.69 $67,020 7,119 D
2022-10-25 Sale : show line 3 in the form −534 $16.20 $8,652 6,585 D
2022-10-26 Sale : show line 4 in the form −1,678 $15.10 $25,342 4,907 D
Open-market sales · 9,350 sh · avg $15.76 · $147,358
Loading xslF345X03/doc4.xml…